Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet

Pre-clinicalCompleted

0 views this week 0 watching💤 Quiet

Interest: 26/100

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Tobacco Dependence

Conditions

Tobacco Dependence

Trial Timeline

Sep 1, 2007 → Nov 1, 2007

NCT ID

NCT01238627

About Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet

Nicotine Sublingual Tablet Mint (NSTM) + Marketed Nicotine Tablet is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01238627. Target conditions include Tobacco Dependence.

What happened to similar drugs?

7 of 10 similar drugs in Tobacco Dependence were approved

Approved (7) Terminated (3) Active (2)

✅Nicotine Gum + Nicotine PatchJohnson & JohnsonApproved

✅Bupropion SRJohnson & JohnsonApproved

✅Varenicline + Nicotine Patch + Placebo Patch + Placebo TabletPfizerApproved

✅1.0mg Varenicline b.i.d. + 0.5mg Varenicline b.i.d. + 0.0mg placebo Varenicline b.i.d.PfizerApproved

✅Varenicline Tartrate + PlaceboPfizerApproved

✅Long-Term Varenicline + Short-Term VareniclinePfizerApproved

✅Varenicline + Nicotine patchRafael HoldingsApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01238627	Pre-clinical	Completed	Sep 1, 2007	Nov 1, 2007	Tobacco Dependence

Competing Products

20 competing products in Tobacco Dependence

See all competitors

Product	Company	Stage	Hype Score
Nicotine + Nicotine + Nicotine	Johnson & Johnson	Pre-clinical	26
Nicotine Gum + Nicotine Patch	Johnson & Johnson	Approved	43
Nicotine Medicated Gum + 4 mg Nicotine Gum + 2 mg Nicotine Gum + 4 mg Nicotine Lozenge	Johnson & Johnson	Pre-clinical	26
Nicotine + Nicotine	Johnson & Johnson	Pre-clinical	26
Nicotine + Nicotine	Johnson & Johnson	Phase 1	29
Nicotine + Nicotine + Nicotine	Johnson & Johnson	Phase 1	29
Nicotine	Johnson & Johnson	Pre-clinical	26
6 mg Experimental nicotine gum + 4 mg Nicotine Gum/ + 2 mg Nicotine Gum	Johnson & Johnson	Pre-clinical	26
Nicorette Strongmint lozenge 4 mg + Niquitin MiniMint lozenge 4 mg	Johnson & Johnson	Phase 1	29
Oral Nicotine + Nicotine Lozenge + Nicotine gum	Johnson & Johnson	Pre-clinical	26
Nicotine + Nicotine Gum	Johnson & Johnson	Pre-clinical	26
Code STD + Code STE + Nicorette Microtab	Johnson & Johnson	Pre-clinical	26
Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine Lozenge	Johnson & Johnson	Pre-clinical	26
Nicotine + Nicorette® (Nicotine Gum)	Johnson & Johnson	Pre-clinical	26
Nicotine + Nicotine Gum	Johnson & Johnson	Pre-clinical	26
Nicotine	Johnson & Johnson	Pre-clinical	26
Nicotine Spray + Placebo	Johnson & Johnson	Phase 3	40
Placebo + Nicotine	Johnson & Johnson	Phase 3	32
Bupropion SR	Johnson & Johnson	Approved	35
Nicorette Extra Mint 2 mg Gum + Nicorette Mint 2 mg Gum + Nicorette Extra Mint 4mg Gum + Nicorette Mint 4 mg Gum	Johnson & Johnson	Phase 1	29